Aim of this study was to compare cerebrospinal fluid (CSF) virological control, biomarkers and neurocognition of neurologically symptomatic patients on dual antiretroviral therapies (DT) versus 2NRTIs-based three-drug regimens (TT).
Dual antiretroviral therapies are effective and safe regimens in the central nervous system of neurologically symptomatic people living with HIV
Trunfio, Mattia;Rugge, Walter;Mighetto, Lorenzo;Atzori, Cristiana;Nigra, Marco;Borgogno, Enrica;Guastamacchia, Giulia;Bonora, Stefano;Di Perri, Giovanni;Calcagno, Andrea
2020-01-01
Abstract
Aim of this study was to compare cerebrospinal fluid (CSF) virological control, biomarkers and neurocognition of neurologically symptomatic patients on dual antiretroviral therapies (DT) versus 2NRTIs-based three-drug regimens (TT).
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Dual CSF Trunfio AIDS 2020 postprint.pdf
Open Access dal 02/07/2021
Tipo di file:
POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione
582.82 kB
Formato
Adobe PDF
|
582.82 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
